PharmAthene Email Format
Biotechnology ResearchMaryland, United States51-200 Employees
PharmAthene is a biotechnology research company headquartered in Annapolis, Maryland, founded in 2001. Its work centers on developing new medical solutions that aim to improve safety, efficacy, and cost-effectiveness relative to current therapies, with a focus on strengthening national health security. The firm seeks to identify and advance products and technologies deemed urgent procurement priorities by the United States and other governments. The company's product portfolio includes candidates intended to defend against biological threats and chemical exposure, including an anthrax vaccine candidate, a chemical nerve agent bioscavenger, and an anthrax-targeted monoclonal antibody. This positioning places PharmAthene within the biodefense segment of the biotechnology industry, aligning its activities with government priorities for mission-critical medical countermeasures.